Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL ...
Glenmark Pharmaceuticals Ltd is quoting at Rs 1380.8, up 3.49% on the day as on 12:49 IST on the NSE. The stock is up 49.05% in last one year as compared to a 0.46% fall in NIFTY and a 4.57% fall in ...
According to Krishan, the stock is a 'buy' at the current level, with a target price of Rs 640 and a stop loss of Rs 595. It ...
Mahindra & Mahindra is working to scale up some of its smaller businesses to match its portfolio of multiple large companies, ...
The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark ...
Glenmark Pharmaceuticals acquires and launches Acetylcysteine Injection in the US market, strengthening its injectable ...
Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has ...
According to the U.S. health agency, Glenmark Pharmaceuticals is recalling over 15 lakh bottles of a generic drug used to ...
Glenmark’s Acetylcysteine Injection (DEL) is approved based on the safety and efficacy derived from the reference drug ...
Glenmark Pharmaceuticals has launched injection Acetylcysteine in the US after acquiring its abbreviated new drug application ...
Glenmark Pharmaceuticals has acquired generic Acetylcysteine injection for acetaminophen overdose treatment and launched it ...
Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results